Financial Disclosure: Dr Wagner reports receiving past research support from Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Forest Laboratories GlaxoSmithKline, Johnson & Johnson, Novartis, Organon, Pfizer, and Wyeth-Ayerst and is a consultant/advisory board member for Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Cyberonics, Eli Lilly, Forest Laboratories, GlaxoSmithKline, Janssen, Jazz Pharmaceuticals, Novartis, Organon, Ortho-McNeil, Otsuka, Pfizer, Solvay, UCB Pharma, and Wyeth Ayerst. Dr Emslie reports receiving research support from Biobehavioral Diagnostics Inc, Eli Lilly, Forest Laboratories, Organon, Shire, and Somerset; consulting for Biobehavioral Diagnostics Inc, Eli Lilly, GlaxoSmithKline, Shire, and Wyeth-Ayerst; and is on the speaker's bureau for McNeil. Dr Asarnow reports consulting on CBT and CBT for depression supported by an unrestricted grant from Pfizer and has funding from Philip Morris; a family member has funding from Bristol-Myers Squibb and has consulted for Roche. Dr Keller reports receiving research support from Pfizer and Wyeth Pharmaceuticals; receiving consulting fees from Abbott, Bristol-Meyers Squibb, CENEREX, Cephalon, Cypress Bioscience, Cyberonics, Forest Laboratories, GlaxoSmithKline, Janssen, JDS, Medtronic, Organon, Novartis, Pfizer, Roche, Sierra Neuropharmaceuticals, Solvay, and Wyeth; and serving on advisory boards for Abbott Laboratories, Bristol-Myers Squibb, CENEREX, Cyberonics, Cypress Bioscience, Forest Laboratories, Janssen, Neuronetics, Novartis, Organon, and Pfizer. Dr Birmaher reports participating in forums sponsored by Abcomm Inc and Solvay Pharmaceuticals Inc; presenting on bipolar disorders in children at a meeting sponsored by Solvay; and receiving royalties from Random House Inc. Dr McCracken reports receiving research support from Bristol-Myers Squibb, Eli Lilly, McNeil, and Shire and consulting fees from Eli Lilly, Janssen, Johnson & Johnson, McNeil, Novartis, Pfizer, Shire, and Wyeth.